IO Biotech raises €127m Series B financing led by HBM Healthcare Investments

– DENMARK, Copenhagen –  IO Biotech, a clinical-stage biopharmaceutical company developing novel, immune-modulating anti-cancer therapies based on its proprietary T-win technology, today announced that the company has raised EUR 127 million in Series B financing led by HBM Healthcare Investments with the participation of existing investors Novo Seeds, Lundbeckfonden Emerge and Sunstone Life Science Ventures.…

CLARK announces completion of €69m Series C funding led by Tencent

– GERMANY, Frankfurt –  CLARK, The digital insurance manager, today announced the completion of its Series C financing round of 69 million euros led by Tencent while existing investors such as Portag3 Ventures, White Star Capital, and Yabeo are also increasing their stake.…

CorWave announces €35m Series C funding for its Left Ventricular Assist Device

– FRANCE, Clichy –  CorWave, developing an implantable heart pump (Left Ventricular Assist Device, LVAD) based on breakthrough technology, the wave membrane pump, today announced that the company has raised €35m from returning investors, Bpifrance, Novo Holdings, Seventure, Sofinnova Partners and Ysios Capital, and three new investors, EIC Fund, Financière Arbevel, and M&L Healthcare.…

Talent4Boards
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.